The artificial ventilation of acute spinal cord damaged patients: a retrospective study of forty-four patients

Paraplegia
B P GardnerK R Krishnan

Abstract

The case histories of the 44 ventilated spinal cord damaged patients who have been treated at the Mersey Regional Spinal Injuries Centre prior to 1985 were reviewed. Complications of ventilation were commoner in patients whose ventilation was initiated prior to transfer to the specialised centre. Inappropriate early management before or during transfer to the spinal injuries centre led to the need for ventilation in several cases. Spinal cord damaged patients should be transferred to a specialised comprehensive centre as soon as possible after injury so that the requirement for ventilation can be minimised, the incidence of cardiac and respiratory arrest reduced, optimal methods of ventilation and weaning employed and global emotional and educational support provided from the outset for the patient and his family.

References

Dec 13, 1975·Lancet·H L FrankelJ M Spalding
Jul 1, 1978·Pacing and Clinical Electrophysiology : PACE·W W Glenn
Jan 1, 1979·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·D GrossP T Macklem
Sep 1, 1979·Chest·J E OvertonN Susman
Aug 1, 1978·Paraplegia·L Burnham, G Werner
Oct 1, 1976·Journal of Applied Physiology·D E Leith, M Bradley
May 1, 1976·Annals of Surgery·W W GlennK R Holschuh
Dec 7, 1985·British Medical Journal·B P GardnerK R Krishnan
Mar 9, 1972·The New England Journal of Medicine·W W GlennR Yasuda
Oct 19, 1972·The New England Journal of Medicine·H PontoppidanE Lowenstein
Oct 5, 1972·The New England Journal of Medicine·H PontoppidanE Lowenstein
Jun 1, 1974·Anesthesiology·J B DownsW W Sutton
Oct 12, 1972·The New England Journal of Medicine·H PontoppidanE Lowenstein
Nov 1, 1973·Journal of Neurosurgery·R BellamyE S Stauffer
May 1, 1966·Paraplegia·D J CHESHIRE, D A Coats
Sep 1, 1970·Clinical Science·A Moulton, J R Silver
Sep 10, 1983·Lancet·B AllolioW Winkelmann
May 1, 1983·The American Review of Respiratory Disease·I M WeismanM H Sanders
Oct 1, 1983·Chest·M L SplaingardL S Jefferson
Jan 1, 1983·Journal of Molecular Evolution·G Schlesinger, S L Miller
Mar 1, 1982·Critical Care Medicine·J AskanaziJ M Kinney
Oct 1, 1980·The Surgical Clinics of North America·W W GlennM L Phelps
Aug 1, 1981·Critical Care Medicine·J B Downs, M E Douglas
Dec 1, 1982·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·A F DiMarcoM D Altose
Jul 30, 1981·The New England Journal of Medicine·M AubierC Roussos
Nov 1, 1981·Critical Care Medicine·A MarinelliJ A Schild
Sep 1, 1981·Journal of Neurology, Neurosurgery, and Psychiatry·J R Silver, R P Lehr
Jan 1, 1980·The American Journal of Medicine·D GrossA Grassino
Feb 1, 1981·The Journal of Surgical Research·T OdaJ Gorfien
Mar 1, 1964·Paraplegia·D J CHESHIRE

Citations

Dec 25, 2009·Journal of Neurotrauma·Steven Casha, Sean Christie
Jan 24, 2002·Spine·P A Ball
Jul 3, 2013·Neurosurgery Clinics of North America·Linton T EvansP A Ball
Jul 31, 2013·Respiratory Physiology & Neurobiology·Daniel J HohMichael A Lane
Jan 30, 2015·Current Treatment Options in Neurology·Ryan A GrantKhalid M Abbed

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.